Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DRUGMODE ApS
APS
Dissolved
Advertising protection
CVR 29600937
Agern Alle 24-26, 2970
Hørsholm
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2006 · 20 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
DRUGMODE ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-2M
2012
-1M
2013
0M
2014
EBITDA
DKK millions
0M
-1M
-1M
-2M
-3M
-2M
2012
-1M
+50%
2013
0M
+100%
2014
Income statement
DKK thousands
Item
2012
2013
2014
Gross profit
-2.492
-1.048
-494
Staff expenses
-0
-0
-0
EBITDA
-2.492
-1.048
-494
Depreciation & amort.
-0
-0
-0
EBIT
-2.492
-1.048
-494
Net financials
-3.135
-3.447
-3.654
Profit before tax
-5.628
-4.496
-4.148
Tax
-191
84
-0
Net profit
-5.436
-4.580
-4.148
Balance sheet
DKK thousands
Item
2012
2013
2014
Total assets
432
217
145
Equity
-66.858
-71.438
-75.587
Long-term debt
0
0
0
Short-term debt
67.291
71.656
75.732
Total debt
67.291
71.656
75.732
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-49429800.0%
This company
2012
2014
Equity ratio
-52059.2%
This company
38.2%
Market median
-136381% vs market
2012
2014
Return on equity
-414835200.0%
This company
18.4%
Market median
-2254539230% vs market
2012
2014
Net profit margin (of gross profit)
-414835200.0%
This company
2012
2014
Asset turnover (of gross profit)
-3.40×
This company
2012
2014
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
2012
2014
Annual reports & filings
Annual report 2014
Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
More on DRUGMODE ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network